As mentioned, the buying is continuing to be strong thereby avoiding a retracement.
Instead it is trading sideways in a narrow range: $2.09-$2.14 since 3 Nov.
Let us hope it manages to do that for another week or so and then start another slow rise till we get some news.
Waiting for that proposed agreement with a major Pharma. This to be followed by 2 listings: the immunology division to be listed in Londen and NAL to be listed at the Nasdaq (ADR).
And what wil be NAL's price in MAY? I won't answer that but the listings ought to replace cheap Aussie prices by upmarket UK and US prices.
I am rating it NAL #3 after NRT and CMQ.
Meeting is on 27 Nov. A lot can happen before that!
Gerry Please do your own research and you decide if and when to buy, hold or sell any stocks.
NAL Price at posting:
0.0¢ Sentiment: None Disclosure: Held